Immune-related adverse events (IRAE) of elderly patients (PTS) with advanced melanoma (AMEL) treated with checkpoint inhibitors (CI) in a community setting: The experience (EXP) at Kaiser Permanente (KP) California.
2018
e21583Background: CI have transformed treatment (TX) and survival for PTS with (w) AMEL. Our knowledge of TX outcomes (OUTC) and IRAEs is still largely informed by clinical trials enrolling younger...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI